Tag Archives: Chronic obstructive pulmonary disease

Feds End Use of Seven Inhalers (But Not All At Once)

By George Koroneos | Published: April 14, 2010

Image by noii’s via Flickr FDA, on Tuesday, announced that it would phase out the use of seven asthma and chronic obstructive pulmonary disease inhalers to keep in check with regulations banning devices containing chlorofluorocarbons (CFCs). Four of the devices have already been discontinued, and the manufacturers of the remaining devices will have to find suitable replacements [...]

Posted in Regulatory, Strategy | Also tagged Abbott Laboratories, Boehringer Ingelheim, CFC, Chlorofluorocarbon, Forest Laboratories, Montreal Protocol, Ozone layer | Leave a comment

Strategic Patient Adherence Awards: “And the Winners Are”

By George Koroneos | Published: May 6, 2009

Pharm Exec was proud to partner this year with CBI on the eighth annual Forum on Patient Compliance, Adherence & Persistency. One of the highlights of the event is the presentation of the Strategic Patient Adherence Awards, which honor pharma-based programs to improve compliance. The winners this year: For best branded program AstraZeneca Canada for a program [...]

Posted in Events | Also tagged Anastrozole, Blood pressure, Breast cancer, Conditions and Diseases, Feedback, Health, hypertension | Leave a comment